Old Web
English
Sign In
Acemap
>
authorDetail
>
Kamonwan Kongrak
Kamonwan Kongrak
St. Vincent's Health System
Medicine
Oncology
Chemotherapy
Taxane
Internal medicine
3
Papers
10
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Final results of a phase I/II prospective dose escalation trial evaluating safety and efficacy of combination 177Lu PSMA 617 and NOX66 in men with end-stage metastatic castration-resistant prostate cancer (LuPIN trial).
2021
Journal of Clinical Oncology
Sarennya Pathmanandavel
Megan Crumbaker
Andrew On Wah Yam
Christopher Rofe
Bao Ho
Wai Ling Chan
Shikha Sharma
Adam Hickey
Kamonwan Kongrak
Lalith Ratnayake
Edmond M. Kwan
Arun Azad
Peter Eu
Andrew Nguyen
Anthony M. Joshua
Louise Emmett
Show All
Source
Cite
Save
Citations (0)
Phase I/II Trial of the Combination of 177Lutetium Prostate specific Membrane Antigen 617 and Idronoxil (NOX66) in Men with End-stage Metastatic Castration-resistant Prostate Cancer (LuPIN).
2020
European Urology Oncology
Megan Crumbaker
Sarennya Pathmanandavel
Andrew O. Yam
Andrew Nguyen
Bao Ho
Lyn Chan
Jesse A. Ende
Christopher Rofe
Kamonwan Kongrak
Edmond M. Kwan
Arun Azad
Shikha Sharma
Trevor J. Pugh
Arnavaz Danesh
Joanne Keane
Peter Eu
Anthony M. Joshua
Louise Emmett
Show All
Source
Cite
Save
Citations (9)
Updated results of a phase I/II prospective dose escalation trial evaluating safety and efficacy of combination 177Lu PSMA 617 and idronoxil in men with mCRPC post androgen signalling inhibition and taxane chemotherapy (LuPIN trial).
2020
Journal of Clinical Oncology
Louise Emmett
Sarennya Pathmanandavel
Megan Crumbaker
Christopher J Rofe
Andrew On Wah Yam
Bao Ho
Wai Ling Chan
Shikha Sharma
Joanne Keane
Adam Hickey
Karen Fullard
Kamonwan Kongrak
Lalith Ratnayake
John Violet
Arun Azad
Peter Eu
Andrew Nguyen
Anthony M. Joshua
Show All
Source
Cite
Save
Citations (1)
1